MedPath
HSA Approval

BIFEN SUSPENSION 100 mg/5 ml

SIN08932P

BIFEN SUSPENSION 100 mg/5 ml

BIFEN SUSPENSION 100 mg/5 ml

September 20, 1996

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

M01AE01

ibuprofen

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PT ACTAVIS INDONESIA

Active Ingredients

IBUPROFEN

100 mg/5 ml

Ibuprofen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BIFEN SUSPENSION 100 mg/5 ml - HSA Approval | MedPath